Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest Articles52-Week Treatment with Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycaemic Control in Men with Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone
Journal of Andrology, 07/09/09
Heufelder AE et al. - Men with the metabolic syndrome (MetS) and type 2 diabetes (T2D) often have low testosterone levels. Elevating low testosterone levels may improve features of the MetS and glycemic control. Addition of testosterone to supervised D&E results in greater therapeutic improvements of glycaemic control and reverses the MetS after 52-weeks of treatment in hypogonadal patients with the MetS and newly diagnosed T2D.
Louis J Gooren , 07/10/09
| There is a worldwide sex difference in cardiovascular disease favroring women over men and the classical reflex of physicians has traditionally been to ascribe this to the negative effects of testosterone on cardiovascualr health. The opposite could be true.Men with low levles of testosterone are at risk of the metabolic syndrome, cardiovascular disease and diabetes mellitus type 2. A pivotal question remains whether normalization of testosterone would be helpful in the treatment of diabetes mellitus. Our study showed that over and beyond the benefits of diet and exercise normalization of testosterone levels was a factor in a better metabolic control of diabetes mellitus and redressing the metabolic syndrome. |
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/30/09
Effects of oestradiol on gonadotrophin levels in normal and castrated men
Clinical Endocrinology, 11/18/09
Sponsor
Article Search
Sponsor